Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
16.47
+0.05 (0.30%)
At close: Jun 26, 2026, 4:00 PM EDT
16.95
+0.48 (2.90%)
After-hours: Jun 26, 2026, 7:41 PM EDT
Generate Biomedicines Earnings Call Transcripts
Fiscal Year 2026
-
The platform integrates advanced computational and experimental methods to accelerate novel protein drug discovery, with a lead anti-TSLP antibody in phase III for severe asthma and a robust oncology pipeline. Strategic partnerships and a focus on biannual dosing aim to improve compliance and market impact.